Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a dedicated Locations section with Massachusetts as a site and updated the page revision to v3.3.3. The old 'Massachusetts Locations' label was removed and the HHS Vulnerability Disclosure link was deleted.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not be about the study. The revision note shows the page updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedThe notice about government funding and operating status at the top of the page was removed, an administrative banner that does not alter the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected; the page's study details, eligibility criteria, and plan remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check92 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check99 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.